USFDA gives nod to Granules India’s generic formulation to treat depression

Granules India Limited received USFDA approval for their ANDA for Bupropion Hydrochloride Extended-Release Tablets USP, used for major depressive disorder and seasonal affective disorder. This brings their total number of US FDA approvals to 67, demonstrating their dedication to expanding in the US market and meeting patient healthcare needs.